skip to main content

Disease Burden Analysis of Cervical Cancer in Indonesia: A Secondary Analysis of Global Burden of Disease Study 2023

*Arsyatul Nikma  -  Department of Public Health, Universitas Negeri Malang, Jl. Semarang 5, Malang, 65145, East Java, Indonesia, Indonesia
Nurnaningsih Herya Ulfah orcid scopus  -  Department of Public Health, Universitas Negeri Malang, Jl. Semarang 5, Malang, 65145, East Java, Indonesia, Indonesia
Sapto Adi orcid scopus  -  Department of Sport Science, Universitas Negeri Malang, Jl. Semarang 5, Malang, 65145, East Java, Indonesia, Indonesia
Supriyadi Supriyadi  -  Department of Sport Science, Universitas Negeri Malang, Jl. Semarang 5, Malang, 65145, East Java, Indonesia, Indonesia
Received: 4 Jun 2026; Revised: 9 Nov 2026; Accepted: 9 Nov 2026; Available online: 9 Nov 2026; Published: 9 Nov 2026.

Citation Format:
Abstract

Background: In 2023, cervical cancer (CC) accounted for approximately 13.26 million Disability-Adjusted Life Years (DALYs) globally (95% UI: 10.12–17.36 million), exceeding the combined DALY burden of uterine and ovarian cancers (9.38 million DALYs; 95% UI: 7.93–11.04 million). This substantial contribution to the global burden of gynecological cancers underscores the need to understand the Burden of Disease (BoD) of CC, including Years Lived with Disability (YLD), Years of Life Lost (YLL), and DALY as a foundation for the CC elimination program.

Methods: This study conducted a secondary analysis of CC burden estimates from the Global Burden of Disease (GBD) 2023 Study by the Institute for Health Metrics and Evaluation (IHME) to analyze the temporal trends, spatial distribution and autocorrelation, and to forecast the BoD of CC in Indonesia. The age-standardized rates (ASR) of YLD, YLL, and DALY due to CC from 1990 to 2023 were analyzed using joinpoint regression, Global Moran’s I, Local Indicators of Spatial Association (LISA), and Holt’s Double Exponential Smoothing.

Result: Over the full study period (1990–2023), the overall Average Annual Percent Change (AAPC) indicated an increasing trend in CC burden at both national and provincial levels, although segment-specific Annual Percent Change (APC) values varied, with some periods and provinces showing declines. The highest national APC in YLD occurred in 2007–2011, while the highest APC in YLL and DALY occurred in 2018–2021. The Riau Islands had the highest AAPC in YLD. Meanwhile, the highest AAPC for YLL and DALY were recorded in Maluku. The global Moran's I statistic indicated a tendency toward a dispersed pattern, though this was not statistically significant. LISA identified local spatial autocorrelation in East Kalimantan and Gorontalo. Last, the YLD, YLL, and DALY for CC in Indonesia are projected to increase from 2024 to 2028.

Conclusion: The findings of this study suggest that CC remains a substantial public health burden in Indonesia, highlighting the need for continued attention to prevention and control efforts.

Note: This article has supplementary file(s).

Fulltext View|Download |  Statement of Originality
Disease Burden Analysis of Cervical Cancer in Indonesia: A Global Burden of Disease Study 2023
Subject Burden of Disease; Cervical Cancer; YLD; YLL; DALY
Type Statement of Originality
  Download (79KB)    Indexing metadata
 Appendix
Disease Burden Analysis of Cervical Cancer in Indonesia: A Global Burden of Disease Study 2023
Subject Burden of Disease; Cervical Cancer; YLD; YLL; DALY
Type Appendix
  Download (3MB)    Indexing metadata
Email colleagues
Keywords: Burden of Disease; Cervical Cancer; YLD; YLL; DALY
Funding: Universitas Negeri Malang under contract 13.4.278/UN32/KP/2026

Article Metrics:

Article Info
Section: Articles
Language : EN
  1. WHO. World Health Statistics 2023: Monitoring Health for the SDGs, Sustainable Development Goals. 2023
  2. IHME. GBD History | Institute for Health Metrics and Evaluation. November 12, 2025. Accessed November 20, 2025. https://www.healthdata.org/research-analysis/about-gbd/history
  3. Murray CJL. The Global Burden of Disease Study at 30 years. Nature Medicine 2022 28:10. 2022;28(10):2019-2026. doi: 10.1038/S41591-022-01990-1
  4. WHO. WHO Methods and Data Sources for Global Burden of Disease Estimates 2000-2021. 2024. https://www.who.int/data/global-health-estimates
  5. Force LM, Kocarnik JM, May ML, et al. The Global, Regional, and National Burden of Cancer, 1990–2023, with Forecasts to 2050: A Systematic Analysis for the Global Burden of Disease Study 2023. The Lancet. 2025;406(10512):1565-1586. doi: 10.1016/s0140-6736(25)01635-6
  6. IHME. GBD Results. Institute for Health Metrics and Evaluation. October 15, 2025. Accessed April 26, 2026. https://vizhub.healthdata.org/gbd-results/
  7. IARC. Cancer Today - Absolute Numbers, Incidence, Females, in 2022. 2025. Accessed November 24, 2025. https://gco.iarc.fr/today/en/dataviz/pie?mode=population&group_populations=0&sexes=2&cancers=23&populations=104_144_356_360_408_462_50_524_626_64_764
  8. IARC. Cancer Today - Population Factsheets . 2024. Accessed November 21, 2025. https://gco.iarc.who.int/today/en/fact-sheets-populations#global
  9. Karyana, Ida. Forum Global Ke-2 Eliminasi Kanker Serviks: Komitmen Nyata Menuju Eliminasi Kanker Serviks - Badan Kebijakan Pembangunan Kesehatan | BKPK Kemenkes. June 18, 2025. Accessed November 21, 2025. https://www.badankebijakan.kemkes.go.id/forum-global-ke-2-eliminasi-kanker-serviks-komitmen-nyata-menuju-eliminasi-kanker-serviks/
  10. Khairunnisa P, Ronoatmodjo S, Prasetyo S. Faktor-Faktor yang Mempengaruhi Perempuan Melakukan Pemeriksaan Dini Kanker Serviks : A Scoping Review. Jurnal Epidemiologi Kesehatan Indonesia. 2023;6(2). doi: 10.7454/epidkes.v6i2.6256
  11. Madani IGAW, Suarya LMKS. Faktor-Faktor yang Memengaruhi Anticipatory Grief pada Family Caregiver Pasien yang Didiagnosis Kanker: Narrative Literature Review. Jurnal Keperawatan Klinis dan Komunitas (Clinical and Community Nursing Journal). 2025;9(3):178. doi: 10.22146/JKKK.109095
  12. Kristina SA, Endarti D, Aditama H. Prediction of Productivity Costs Related to Cervical Cancer Mortality in Indonesia 2018. Malaysian Journal of Medical Sciences. 2022;29(1):138-144. doi: 10.21315/mjms2022.29.1.13
  13. Pangestu S, Harjanti EP, Pertiwi IH, Rencz F, Nurdiyanto FA. Financial Toxicity Experiences of Patients With Cancer in Indonesia: An Interpretive Phenomenological Analysis. Value Health Reg Issues. 2024;41:25-31. doi: 10.1016/j.vhri.2023.11.007
  14. Kemenkes RI. Rencana Kanker Nasional 2024-2034 Strategi Indonesia dalam Upaya Melawan Kanker. 2024
  15. Kemenkes RI. Profil Kesehatan Indonesia 2024. Kementerian Kesehatan Republik Indonesia; 2025
  16. Kemenkes RI. Profil Kesehatan Indonesia 2023. Kementerian Kesehatan Republik Indonesia; 2024
  17. NCI. Cervical Cancer Prognosis and Survival Rates - NCI. April 27, 2023. Accessed December 13, 2025. https://www.cancer.gov/types/cervical/survival
  18. Cheng LY, Zhao JQ, Zou TT, Xu ZH, Lv Y. Cervical Cancer Burden and Attributable Risk Factors across Different Age and Regions from 1990 to 2021 and Future Burden Prediction: Results from the Global Burden of Disease Study 2021. Front Oncol. 2025;15. doi: 10.3389/fonc.2025.1541452
  19. Li J, Zhao X, Li X, et al. Analysis of the Disease Burden of Malignancies in the Female Reproductive System in China from 1990 to 2019: An Age-Period-Cohort Study and Joinpoint Analysis. BMJ Open . 2025;15(4). doi: 10.1136/bmjopen-2023-081511
  20. Liu PC, Huang TH, Wu YC, et al. Disease Burden of 30 Cancer Groups in Taiwan from 2000 to 2021. J Epidemiol Glob Health. 2025;15(1):62. doi: 10.1007/s44197-025-00406-w
  21. Li Y, Song W, Gao P, et al. Global, Regional, and National Burden of Breast, Cervical, Uterine, and Ovarian Cancer and their Risk Factors among Women from 1990 to 2021, and Projections to 2050: Findings from the Global Burden of Disease Study 2021. BMC Cancer. 2025;25(1). doi: 10.1186/s12885-025-13741-9
  22. Wahidin M, Febrianti R, Susanty F. Burden of Cervical Cancer in Indonesia: Findings from the Global Burden of Disease Study 1990-2017. Advances in Health Research. 2020;22:213-217. doi: 10.2991/ahsr.k.200215.040
  23. Parascandola M, Gila Neta, Salloum RG, Shelley D, Rositch AF. Role of Local Evidence in Transferring Evidence-Based Interventions to Low-and Middle-Income Country Settings: Application to Global Cancer Prevention and Control. JCO Global Oncol. 2022;8:2200054. doi: 10.1200/GO.22
  24. WHO. Evidence, Policy, Impact. WHO Guide for Evidence-Informed Decision-Making. 2021
  25. Kemenkes RI. Peraturan Menteri Kesehatan Republik Indonesia Nomor 12 Tahun 2025 tentang Rencana Strategis Kementerian Kesehatan Tahun 2025-2029. Kementerian Kesehatan Republik Indonesia. October 11, 2025. Accessed December 7, 2025. https://kemkes.go.id/id/permenkes-ri-no-12-tahun-2025-tentang-rencana-strategis-kementerian-kesehatan-tahun-2025-2029
  26. Mboi N, Syailendrawati R, Ostroff SM, et al. The State of Health in Indonesia’s Provinces, 1990–2019: A Systematic Analysis for the Global Burden of Disease Study 2019. Lancet Glob Health. 2022;10(11):e1632-e1645. doi: 10.1016/S2214-109X(22)00371-0
  27. Alfianty S, Putri L. Tingkat Pengetahuan Sadari Pada Remaja Putri. Jurnal Riset Kesehatan Masyarakat. 2023;3(3):159-164. doi: 10.14710/JRKM.2023.18841
  28. Kemenkes RI. Keputusan Menteri Kesehatan Republik Indonesia Nomor HK.01.07/Menkes/349/2018 Tentang Pedoman Nasional Pelayanan Kedokteran Tata Laksana Kanker Serviks. Kementerian Kesehatan Republik Infonesia. Preprint posted online 2018. Accessed April 26, 2026. https://kemkes.go.id/app_asset/file_content_download/17012255346566a43ea12c82.16568012.pdf
  29. NCI. Coping with Cervical Cancer . National Cancer Institute. October 12, 2022. Accessed April 25, 2026. https://www.cancer.gov/types/cervical/coping
  30. Palagudi M, Para S, Golla N, et al. Adverse Effects of Cancer Treatment in Patients With Cervical Cancer. Cureus. 2024;16(2):e54106. doi: 10.7759/CUREUS.54106
  31. Kayar İ, Goc G, Cetin F, Birge Ö. Impact of Smoking on Cervical Histopathological Changes in High-Risk HPV-Positive Women: A Matched Case–Control Study. Medicina (Lithuania). 2025;61(2). doi: 10.3390/medicina61020235
  32. Perdoman AT, Saputra AI, Rahmi Y. Analisis Faktor Risiko pada Kanker Serviks di Rumah Sakit Badan Pengusahaan Batam. Zona Kedokteran: Program Studi Pendidikan Dokter Universitas Batam. 2025;15(2). doi: 10.37776/ZKED.V15I2.1791
  33. BKKBN. Infografik Kinerja Utama Bangga Kencana: Hasil Pemutakhiran Pendataan Keluarga Tahun 2023. 2024
  34. Guo C, Zhan B, Li MY, Yue L, Zhang C. Association Between Oral Contraceptives and Cervical Cancer: A Retrospective Case-Control Study Based on the National Health and Nutrition Examination Survey. Front Pharmacol. 2024;15. doi: 10.3389/FPHAR.2024.1400667
  35. Cahyani NA, Shammakh AA, Sabariah S, Arjite PD. Hubungan Penggunaan Kontrasepsi Hormonal dengan Hasil Pemeriksaan Inspeksi Visual Asam Asetat (IVA). Jurnal Health Sains. 2023;4(4):30-40. doi: 10.46799/JHS.V4I4.876
  36. BPS. Angka Kelahiran Total / Total Fertility Rate (TFR) Menurut Provinsi, 1971-2020. 2023. Accessed May 19, 2026. https://www.bps.go.id/id/statistics-table/1/MjIxMCMx/angka-kelahiran-total---total-fertility-rate--tfr--menurut-provinsi--1971-2020.html
  37. Zeta NK, Oktarlina RZ, Ramdini DA. Hubungan Paritas dengan Kejadian Kanker Serviks: Tinjauan Pustaka. Medula. 2023;13(4):490
  38. BKKBN. Survei Kinerja Dan Akuntabilitas Program KKBPK (SKAP) Tahun 2018. Badan Kependudukan dan Keluarga Berencana Nasional Pusat Penelitian dan Pengembangan Keluarga Berencana dan Keluarga Sejahtera; 2018
  39. Kemenkes RI. Profil Kesehatan Indonesia Tahun 2016. Kementerian Kesehatan Republik Indonesia; 2017. http://www.kemkes.go.id
  40. Wan Z, Wang Y, Deng C. Application of GIS Spatial Analysis and Scanning Statistics in the Gynecological Cancer Clustering Pattern and Risk Screening: A Case Study in Northern Jiangxi Province, China. Risk Manag Healthc Policy. 2020;13:1079-1093. doi: 10.2147/RMHP.S261221
  41. Sousa LV de A, Maciel E da S, Paiva L da S, et al. Inequalities in Mortality and Access to Hospital Care for Cervical Cancer-An Ecological Study. Int J Environ Res Public Health. 2021;18(20). doi: 10.3390/IJERPH182010966
  42. Spagnoletti BRM, Atikasari H, Ramania A, Bennett L. Program Screening Kanker Serviks di Indonesia Terhenti Karena COVID-19, Risiko Kematian Perempuan Makin Tinggi. Nurhasim A, ed. The Conversation. October 1, 2020. doi: 10.64628/AAN.6C9CATXF5
  43. Popescu A, Craina M, Pantea S, et al. COVID-19 Pandemic Effects on Cervical Cancer Diagnosis and Management: A Population-Based Study in Romania. Diagnostics (Basel). 2022;12(4). doi: 10.3390/DIAGNOSTICS12040907
  44. Ariningrum R, Musadad DA, Sugiharto M, Karlina K, Arianto G. Implementing Essential Health Service Efforts Policy During the Covid 19 Pandemic in Banjar Baru City and Hulu Sungai Tengah Regency, South Kalimantan Province. Jurnal Analis Kebijakan. 2023;6(2):49-59. doi: 10.37145/JAK.V6I2.534
  45. Frick C, Rumgay H, Vignat J, et al. Quantitative Estimates of Preventable and Treatable Deaths from 36 Cancers Worldwide: A Population-Based Study. Lancet Glob Health. 2023;11(11):e1700-e1712. doi: 10.1016/S2214-109X(23)00406-0
  46. IKP. Pemkot Ambon Perkenalkan Metode Skrining Kanker Serviks dengan HPV DNA - Kota Ambon. Pemerintah Kota Ambon. November 4, 2025. Accessed April 26, 2026. https://ambon.go.id/pemkot-ambon-perkenalkan-metode-skrining-kanker-serviks-dengan-hpv-dna/
  47. Malawat R, Rahmawati WO, Ratulohain C. Pengaruh Sikap Wanita Usia Subur terhadap Kepatuhan Deteksi Dini Kanker Serviks Melalui Pemeriksaan IVA Test di Puskesmas Hitu Maluku Tengah. Jurnal Kebidanan. 2025;5(1):53-62. doi: 10.32695/JBD.V5I1.566
  48. Muhawarman A. Wamenkes Tegaskan Komitmen Eliminasi Kanker Leher Rahim 2030 melalui Skrining DNA HPV Terintegrasi. January 26, 2026. Accessed May 3, 2026. https://kemkes.go.id/id/wamenkes-tegaskan-komitmen-eliminasi-kanker-leher-rahim-2030-melalui-skrining-dna-hpv-terintegrasi
  49. Haemmerli M, Powell-Jackson T, Goodman C, Thabrany H, Wiseman V. Poor Quality for the Poor? A Study of Inequalities in Service Readiness and Provider Knowledge in Indonesian Primary Health Care Facilities. International Journal for Equity in Health 2021 20:1. 2021;20(1):239-. doi: 10.1186/S12939-021-01577-1
  50. BPS. Tingkat Penyelesaian Pendidikan Menurut Jenjang Pendidikan dan Provinsi. Badan Pusat Statistik Indonesia. April 21, 2024. Accessed May 21, 2026. https://www.bps.go.id/id/statistics-table/2/MTk4MCMy/tingkat-penyelesaian-pendidikan-menurut-jenjang-pendidikan-dan-provinsi.html
  51. BPS. Angka Partisipasi Sekolah (APS) Menurut Provinsi dan Kelompok Umur. Badan Pusat Statistik Indonesia. December 11, 2025. Accessed May 21, 2026. https://www.bps.go.id/id/statistics-table/2/MjIxMSMy/angka-partisipasi-sekolah--aps--menurut-provinsi-dan-kelompok-umur.html
  52. BPS. Angka Harapan Hidup (AHH) Menurut Provinsi dan Jenis Kelamin. Badan Pusat Statistik Indonesia. March 26, 2025. Accessed May 21, 2026. https://www.bps.go.id/id/statistics-table/2/NTAxIzI=/angka-harapan-hidup-ahh-menurut-provinsi-dan-jenis-kelamin.html
  53. Prawiradiharjo AAA, Rahaju T, Prabawati I, Hilmi AN. Implementasi Kebijakan Pembangunan Infrastruktur di Perbatasan: Studi Kasus Rumah Sakit Kelas D Pratama Sebatik. Publika. 2026;14(1):137-144. doi: 10.1177/009539977500600404
  54. Paremajangga RA, Ndoen HI, Riwu YR. Faktor Risiko yang Berhubungan dengan Kejadian Lesi Prakanker Serviks (IVA+) di Puskesmas Bakunase Kota Kupang Tahun 2019. Media Kesehatan Masyarakat. 2020;2(1):1-9. doi: 10.35508/MKM.V2I1.2011
  55. He R, Zhu B, Liu J, Zhang N, Zhang WH, Mao Y. Women’s Cancers in China: A Spatio-temporal Epidemiology Analysis. BMC Womens Health. 2021;21(1). doi: 10.1186/s12905-021-01260-1
  56. Majoumerd AA, Hosseini S, Hosseini SMH, Roshandel G, Rahmanian V, Hazar N. Epidemiology of Cervical Cancer in Iran in 2016: A Nationwide Study of Incidence and Regional Variation. Cancer Rep. 2024;7(2). doi: 10.1002/cnr2.1973
  57. BPS. Persentase Unmet Need Pelayanan Kesehatan Menurut Provinsi. Badan Pusat Statistik Indonesia. December 11, 2025. Accessed May 21, 2026. https://www.bps.go.id/id/statistics-table/2/MTQwMiMy/unmet-need-pelayanan-kesehatan-menurut-provinsi.html
  58. Wahidin M, Febrianti R, Susanty F, Hasanah SR. Twelve Years Implementation of Cervical and Breast Cancer Screening Program in Indonesia. Asian Pac J Cancer Prev. 2022;23(3):829-837. doi: 10.31557/APJCP.2022.23.3.829
  59. Muharram FR, Sulistya HA, Swannjo JB, et al. Adequacy and Distribution of the Health Workforce in Indonesia. WHO South East Asia J Public Health. 2024;13(2):45-55. doi: 10.4103/WHO-SEAJPH.WHO-SEAJPH_28_24
  60. Andriani Y, Kristina SA, Wiedyaningsih C. Estimasi Biaya Pengobatan Langsung Penyakit Kanker di Indonesia: Estimasi Direct Medical Cost (DMC). Majalah Farmaseutik. 2021;17(3):251-255. doi: 10.22146/farmaseutik.v1i1.49823
  61. Sabale U, Bencina G, Subash V, et al. The Productivity Loss Associated with HPV-related Cancer Mortality in Europe; Years of Life Lost and Productivity Costs. J Med Econ. 2024;27(sup2):62-74. doi: 10.1080/13696998.2025.2528518
  62. Wu S, Jiao J, Yue X, Wang Y. Cervical Cancer Incidence, Mortality, and Burden in China: A Time-trend Analysis and Comparison with England and India Based on the Global Burden of Disease Study 2019. Front Public Health. 2024;12:1358433. doi: 10.3389/FPUBH.2024.1358433/FULL
  63. Yang Y, Miao R, He H, et al. The Burden and Trends of Gynecological Cancers in Asia from 1980 to 2021, with Projections to 2050: A Systematic Analysis for the Global Burden of Disease Study 2021. Curr Oncol. 2025;32(6). doi: 10.3390/CURRONCOL32060298
  64. Simms KT, Keane A, Nguyen DTN, et al. Benefits, Harms and Cost-effectiveness of Cervical Screening, Triage and Treatment Strategies for Women in the General Population. Nat Med. 2023;29(12):3050. doi: 10.1038/S41591-023-02600-4
  65. WHO. Immunization, Vaccines and Biologicals (HPV Dashboard). Country Profile Area. April 14, 2026. Accessed May 21, 2026. https://www.who.int/teams/immunization-vaccines-and-biologicals/diseases/human-papillomavirus-vaccines-(HPV)/hpv-clearing-house/hpv-dashboard

Last update:

No citation recorded.

Last update:

No citation recorded.